[Ruiding GFC Reproductive Hospital Success Story] Ms. Liu, 38, Achieves Pregnancy After Three IVF Cycles

After eight years of marriage and relentless dedication to her career, 38-year-old Ms. Liu stood at a crossroads between professional success and family aspirations—until she finally welcomed the long-awaited 'good pregnancy'曙光 following her third IVF attempt.

At 38, Ms. Liu had long stood at a crossroads between career and family—until she finally experienced a life-changing turning point. Married for eight years, she had devoted herself wholeheartedly to her career, navigating the competitive business world with resilience and determination, carving out her own professional territory. Yet as her career stabilized and her age quietly advanced, the pressing matter of childbearing loomed like an immense, weighty mountain over both her and her husband.

With high hopes, the couple embarked on their conception journey—yet after six months, there was still no sign of pregnancy. Aware that her age was no longer in the optimal fertility window, they wasted no time and promptly sought medical assistance.

A series of diagnostic tests delivered a cold, clinical verdict that pierced their hearts like a sharp blade. Ms. Liu was diagnosed with bilateral tubal occlusion and premature ovarian insufficiency; her husband’s sperm DNA fragmentation rate was found to be abnormally high. These technical terms formed an invisible yet unyielding wall—blocking their path to parenthood and leaving them overwhelmed with confusion and helplessness.

In despair, in vitro fertilization (IVF) became their last lifeline. They placed their faith in science’s power to bypass these formidable reproductive barriers. Reality, however, struck them hard. During their first IVF cycle, although six oocytes were successfully retrieved, only two embryos were obtained. Two embryo transfers followed: one ended in failure; the other achieved implantation but unfortunately resulted in miscarriage. Their second IVF cycle proved equally devastating—ending once again in disappointment.

Back-to-back setbacks plunged Ms. Liu and her husband into profound disappointment and despair. Yet deep within her ran an indomitable spirit—refusing to surrender. Clinging to a final glimmer of hope, she consulted our IVF specialists. Meticulously reviewing their test reports and prior treatment history—like seasoned detectives scrutinizing every clue—the experts designed a fully personalized, evidence-based treatment protocol tailored precisely to their unique clinical profile.

Armed with renewed hope, Ms. Liu resumed her IVF journey. This time, fate appeared to finally answer her call. In her third IVF cycle, she retrieved 13 mature oocytes; preimplantation genetic screening (PGS) identified three euploid blastocysts suitable for transfer.

Although the first embryo transfer did not result in pregnancy, those remaining three blastocysts represented three precious chances at renewal—reigniting her resolve to persevere. She knew her uterine lining was relatively thin, presenting yet another challenge on her path to motherhood—but rather than succumbing, she responded with unwavering determination. She began optimizing her physical condition holistically: refining her diet, regulating sleep patterns, incorporating gentle exercise, and nurturing emotional well-being. The synergy of psychological resilience and expert clinical care infused powerful momentum into her fertility journey.

Finally, after the second embryo transfer, the long-awaited, exhilarating news broke through the long darkness like a warm ray of sunlight—her pregnancy test was positive, with an hCG level of 316. In that moment, Ms. Liu and her husband embraced and wept—every moment of waiting, every ounce of effort transformed instantly into tears of pure, unbridled joy. They had finally welcomed their own 'good pregnancy'曙光.

[图片:https://cdn.yun.sooce.cn/6/59417/jpg/1748504529982271be690f071a8d09a81b6c79d9946c2.jpg?version=0][Caption]

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.